T 0194/15 (Anti-TNF antibodies and methotrexate/THE KENNEDY TRUST) of 09.03.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T019415.20160309
- Date of decision
- 9 March 2016
- Case number
- T 0194/15
- Petition for review of
- -
- Application number
- 05076131.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Anti-TNF antibodies and methotrexate in the concomitant treatment of autoimmune diseases
- Applicant name
- The Kennedy Trust for Rheumatology Research
- Opponent name
- Celltrion, Inc. (opposition withdrawn)
Althausen, Sonja
Hospira UK Limited (opposition withdrawn)
AbbVie Inc.
Eiseler, Alice - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 106(1)European Patent Convention Art 107
- Keywords
- Admissibility of appeal - (yes)
Validity of transfer of opponent status - (no)
Remittal to the opposition division - (yes) - Catchword
- -
Order
For these reasons it is decided that:
1. The appeal is held admissible.
2. The decision under appeal is set aside.
3. The case is remitted to the opposition division with the order to continue the opposition proceedings with Abbott Laboratories as opponent 4.